Quote | Liminal Biosciences Inc (NASDAQ:LMNL)
Last: | $8.50 |
---|---|
Change Percent: | 0.24% |
Open: | $8.48 |
Close: | $8.50 |
High: | $8.5 |
Low: | $8.48 |
Volume: | 5,095 |
Last Trade Date Time: | 09/25/2023 03:00:00 am |
News | Liminal Biosciences Inc (NASDAQ:LMNL)
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023
Message Board Posts | Liminal Biosciences Inc (NASDAQ:LMNL)
Subject | By | Source | When |
---|---|---|---|
Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP | Awl416 | investorshub | 07/12/2023 11:33:35 AM |
$LMNL Price trading | pennygame$10 | investorshub | 07/09/2023 11:41:50 PM |
The now last up | rynlrt | investorshub | 07/09/2023 2:42:09 PM |
$LMNL Lets go go go go... Up up and away we go. | ZimZum | investorshub | 07/07/2023 10:43:18 PM |
MomentumIts now | $treet $inatra | investorshub | 07/04/2023 12:40:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Liminal Biosciences Inc Company Name:
LMNL Stock Symbol:
NASDAQ Market:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023
LAVAL, QC and CAMBRIDGE, England, Sept. 26, 2023 /PRNewswire/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") i...